Purpose The protective effect of amifostine against cyclophosphamide (CP) was evaluated on mouse oocytes. Materials and methods Female mice were divided into four groups as follows: group1: cyclophosphamide (CP) (75 mg/kg, i.p) injection, group2: amifostine (250 mg/kg, i.p) injection, group3: amifostine (250 mg/kg, i.p) administered prior to CP (75 mg/kg, i.p) injection, Control group with injection of saline. About 21 days after injection, in vitro maturation (IVM) of oocytes was recorded. Furthermore the percentage of aneuploid oocytes was determined. Results In the CP group IVM rate was significantly decreased and aneploidy rate was significantly increased when compared to other groups (p<0.05). With the administration of Amifostine prior to CP injection IVM rate was increased and aneploidy rate was decreased. Discussion Depletion in IVM rate with administration of CP is due its adverse effects on oocyte quality. Amifostine administration prior to CP injection appears to modulate deleterious effects of CP on oocytes.